Autoantibodies to ACE2 and immune molecules are associated with COVID-19 disease severity
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Autoantibodies to ACE2 and immune molecules are associated with COVID-19 disease severity ; volume:4 ; number:1 ; day:15 ; month:3 ; year:2024 ; pages:1-10 ; date:12.2024
Communications medicine ; 4, Heft 1 (15.3.2024), 1-10, 12.2024
- Creator
-
Geanes, Eric S.
McLennan, Rebecca
LeMaster, Cas
Bradley, Todd
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s43856-024-00477-z
- URN
-
urn:nbn:de:101:1-2405172123590.138227650798
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:54 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Geanes, Eric S.
- McLennan, Rebecca
- LeMaster, Cas
- Bradley, Todd
- SpringerLink (Online service)
Other Objects (12)
Angiotensin type-1 receptor and ACE2 autoantibodies in Parkinson´s disease
ACE2 polymorphisms impact COVID-19 severity in obese patients
Immune response profiling identifies autoantibodies specific to Moyamoya patients
Genotype variation of ACE and ACE2 genes affects the severity of COVID-19 patients
Analyzing the role of ACE2, AR, MX1 and TMPRSS2 genetic markers for COVID-19 severity
The association among leukocyte apoptosis, autoantibodies and disease severity in systemic lupus erythematosus
Atopic dermatitis and autoimmunity: the occurrence of autoantibodies and their association with disease severity
Functional Characterization of ACE2 Regulation in SARS-CoV-2-Infection-Associated Immune Response
Immune modulation by molecules of Staphylococcus aureus
Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID19
Genetic association of ACE2 and TMPRSS2 polymorphisms with COVID-19 severity; a single centre study from Egypt
Serum ACE2 and S19P gene polymorphism in Egyptian patients with COVID-19 infection: correlation with disease severity
Angiotensin type-1 receptor and ACE2 autoantibodies in Parkinson´s disease
ACE2 polymorphisms impact COVID-19 severity in obese patients
Immune response profiling identifies autoantibodies specific to Moyamoya patients
Genotype variation of ACE and ACE2 genes affects the severity of COVID-19 patients
Analyzing the role of ACE2, AR, MX1 and TMPRSS2 genetic markers for COVID-19 severity
The association among leukocyte apoptosis, autoantibodies and disease severity in systemic lupus erythematosus
Atopic dermatitis and autoimmunity: the occurrence of autoantibodies and their association with disease severity
Functional Characterization of ACE2 Regulation in SARS-CoV-2-Infection-Associated Immune Response
Immune modulation by molecules of Staphylococcus aureus
Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID19
Genetic association of ACE2 and TMPRSS2 polymorphisms with COVID-19 severity; a single centre study from Egypt
Serum ACE2 and S19P gene polymorphism in Egyptian patients with COVID-19 infection: correlation with disease severity
Angiotensin type-1 receptor and ACE2 autoantibodies in Parkinson´s disease
ACE2 polymorphisms impact COVID-19 severity in obese patients
Immune response profiling identifies autoantibodies specific to Moyamoya patients
Genotype variation of ACE and ACE2 genes affects the severity of COVID-19 patients
Analyzing the role of ACE2, AR, MX1 and TMPRSS2 genetic markers for COVID-19 severity
The association among leukocyte apoptosis, autoantibodies and disease severity in systemic lupus erythematosus
Atopic dermatitis and autoimmunity: the occurrence of autoantibodies and their association with disease severity
Functional Characterization of ACE2 Regulation in SARS-CoV-2-Infection-Associated Immune Response
Immune modulation by molecules of Staphylococcus aureus
Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID19
Genetic association of ACE2 and TMPRSS2 polymorphisms with COVID-19 severity; a single centre study from Egypt